June 2022
Volume 63, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2022
Agreement of glaucoma progression diagnosis between optic disc and macular retinal structure change in a 3-year prospective observational study
Author Affiliations & Notes
  • Daisuke Shiba
    Ophthalmology, Keio University School of Medicine, Japan
  • Sayaka Adachi
    Ophthalmology, Keio University School of Medicine, Japan
  • Kenya Yuki
    Ophthalmology, Keio University School of Medicine, Japan
  • Kazuno Negishi
    Ophthalmology, Keio University School of Medicine, Japan
  • Footnotes
    Commercial Relationships   Daisuke Shiba Santen, Senju Pharmaceutical, Kowa, Otsuka Pharmaceutical, Nidek, Code F (Financial Support), Santen, Senju Pharmaceutical, Glaukos Japan, Kowa, Otsuka Pharmaceutical, Novartis Japan, Nidek, SEED, Nitto Medic, Code R (Recipient); Sayaka Adachi None; Kenya Yuki None; Kazuno Negishi None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2022, Vol.63, 645 – A0385. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Daisuke Shiba, Sayaka Adachi, Kenya Yuki, Kazuno Negishi; Agreement of glaucoma progression diagnosis between optic disc and macular retinal structure change in a 3-year prospective observational study. Invest. Ophthalmol. Vis. Sci. 2022;63(7):645 – A0385.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To investigate agreement of glaucoma progression diagnosis between optic disc and macula by regression analysis of retinal structures measured with spectral-domain optical coherence tomography (SD-OCT) in a prospective observational cohort study.

Methods : Primary open angle glaucoma patients with visual field defect above -18dB of mean deviation value were included in this prospective study. Exclusion criteria were eyes with ocular diseases including cataract, abnormality history of intraocular surgery except successful glaucoma surgery, and the onset of other ocular diseases during study period that may influence the SD-OCT measurement. The circum-papillary retinal nerve fiber layer (cpRNFL) thickness and macular ganglion cell complex (GCC) thickness were measured using SD-OCT (NIDEK RS-3000 Advance) during three years with arbitrary intervals less than six months. Linear regression analysis of cpRNFL thicknesses in temporal, superior, nasal and inferior quadrants and GCC thicknesses in superior macula and inferior macula were performed with build-in software of the SD-OCT. A statistically significant thinnings in any area were defined as glaucoma progression (P < 0.05).

Results : 48 eyes of 48 glaucoma patients were included. Age and mean deviation at baseline visit were 61 ± 8.7 (mean ± standard deviation) years old and -5.7 ± 4.8dB. cpRNFL thinning rates (thickness at baseline) in temporal, superior, nasal and inferior quadrants were -0.38 ± 1.21 μm/y (57.9 ± 17.5 μm) , –1.49 ± 2.07 μm/y (90.3 ± 21.2 μm), 0.0 ± 1.4 μm/y (74.3 ± 14.4 μm) and -0.21 ± 1.63 μm/y (.2 ± 27.8 μm), respectively. GCC thinning rates (thickness at baseline) in suprerior and inferior macula were -0.18 ± 0.84 μm/y (84.6 ± 11.8 μm) and -0.07 ± 0.83 μm/y (74.7 ± 15.5 μm). Twenty four and 17 eyes were diagnosed as glaucoma progression by by cpRNFL and GCC, respectively, those were overlapped in 11 eyes. Kappa value was 0.21.

Conclusions : Agreement of glaucoma progression diagnosis was fair between cpRNFL thinning and macular GCC thinning.

This abstract was presented at the 2022 ARVO Annual Meeting, held in Denver, CO, May 1-4, 2022, and virtually.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×